Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed. 1 Number Explains Why They're Not Even Close Anymore.
Written by Matthew Benjamin for The Motley Fool -> Both companies are giants in diabetes and obesity treatments. Lately, Eli Lilly has moved ahead in the obesity segment. Things could change, howev
Nasdaq News — 31 July 2026
Text:
31
0
0
Both companies are giants in diabetes and obesity treatments.
Things could change, however, as both firms continue to innovate.
Eli Lilly (NYSE: LLY
Read Full Story at Nasdaq News → Sources
📈 Markets & Finance
Little Movement Seen For Thai Stock Market
📈 Markets & Finance
Trump finalizes new tariffs on dozens of countries
📈 Markets & Finance
Where Will Solana Be in 3 Years?
📈 Markets & Finance
Sophie Cunningham shares special moment with Brittney Griner before Fever-Sun game
📈 Markets & Finance
Ethereum Foundation adds SEAL 911 co-founder to board as privacy focus grows
📈 Markets & Finance
American Airlines Cut Its Full-Year Guidance. The Stock Rose 6.8% the Next Day.
